Cargando…

Innate immune activation as cofactor in pemphigus disease manifestation

Molecular mechanisms underlying auto-antibody-induced acantholysis in pemphigus vulgaris are subject of current research to date. To decipher the discrepancy between ubiquitous antibody binding to the epidermal desmosomes, but discontinuous disease manifestation, we were able to identify Ultraviolet...

Descripción completa

Detalles Bibliográficos
Autores principales: Eichkorn, Ramona A., Schmidt, Morna F., Walter, Elias, Hertl, Michael, Baron, Jens Malte, Waschke, Jens, Yazdi, Amir S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343989/
https://www.ncbi.nlm.nih.gov/pubmed/35928825
http://dx.doi.org/10.3389/fimmu.2022.898819
_version_ 1784761114402226176
author Eichkorn, Ramona A.
Schmidt, Morna F.
Walter, Elias
Hertl, Michael
Baron, Jens Malte
Waschke, Jens
Yazdi, Amir S.
author_facet Eichkorn, Ramona A.
Schmidt, Morna F.
Walter, Elias
Hertl, Michael
Baron, Jens Malte
Waschke, Jens
Yazdi, Amir S.
author_sort Eichkorn, Ramona A.
collection PubMed
description Molecular mechanisms underlying auto-antibody-induced acantholysis in pemphigus vulgaris are subject of current research to date. To decipher the discrepancy between ubiquitous antibody binding to the epidermal desmosomes, but discontinuous disease manifestation, we were able to identify Ultraviolet A (UVA) as a cofactor for acantholysis. UVA induces interleukin (IL)-1 secretion in keratinocytes, mirroring innate immune system activation. In an in vitro keratinocyte dissociation assay increased fragmentation was observed when UVA was added to anti-Desmoglein 3 Immunoglobulins (anti-Dsg3 IgG). These results were confirmed in skin explants where UVA enhanced anti-Dsg3-mediated loss of epidermal adhesion. The UVA-mediated effect was blocked in vitro by the pan-caspase-inhibitor zVAD-fmk. Thus, we introduce UVA as a caspase-dependent exogenous cofactor for acantholysis which suggests that local innate immune responses largely contribute to overt clinical blister formation upon autoantibody binding to epidermal cells in pemphigus vulgaris.
format Online
Article
Text
id pubmed-9343989
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93439892022-08-03 Innate immune activation as cofactor in pemphigus disease manifestation Eichkorn, Ramona A. Schmidt, Morna F. Walter, Elias Hertl, Michael Baron, Jens Malte Waschke, Jens Yazdi, Amir S. Front Immunol Immunology Molecular mechanisms underlying auto-antibody-induced acantholysis in pemphigus vulgaris are subject of current research to date. To decipher the discrepancy between ubiquitous antibody binding to the epidermal desmosomes, but discontinuous disease manifestation, we were able to identify Ultraviolet A (UVA) as a cofactor for acantholysis. UVA induces interleukin (IL)-1 secretion in keratinocytes, mirroring innate immune system activation. In an in vitro keratinocyte dissociation assay increased fragmentation was observed when UVA was added to anti-Desmoglein 3 Immunoglobulins (anti-Dsg3 IgG). These results were confirmed in skin explants where UVA enhanced anti-Dsg3-mediated loss of epidermal adhesion. The UVA-mediated effect was blocked in vitro by the pan-caspase-inhibitor zVAD-fmk. Thus, we introduce UVA as a caspase-dependent exogenous cofactor for acantholysis which suggests that local innate immune responses largely contribute to overt clinical blister formation upon autoantibody binding to epidermal cells in pemphigus vulgaris. Frontiers Media S.A. 2022-07-19 /pmc/articles/PMC9343989/ /pubmed/35928825 http://dx.doi.org/10.3389/fimmu.2022.898819 Text en Copyright © 2022 Eichkorn, Schmidt, Walter, Hertl, Baron, Waschke and Yazdi https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Eichkorn, Ramona A.
Schmidt, Morna F.
Walter, Elias
Hertl, Michael
Baron, Jens Malte
Waschke, Jens
Yazdi, Amir S.
Innate immune activation as cofactor in pemphigus disease manifestation
title Innate immune activation as cofactor in pemphigus disease manifestation
title_full Innate immune activation as cofactor in pemphigus disease manifestation
title_fullStr Innate immune activation as cofactor in pemphigus disease manifestation
title_full_unstemmed Innate immune activation as cofactor in pemphigus disease manifestation
title_short Innate immune activation as cofactor in pemphigus disease manifestation
title_sort innate immune activation as cofactor in pemphigus disease manifestation
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343989/
https://www.ncbi.nlm.nih.gov/pubmed/35928825
http://dx.doi.org/10.3389/fimmu.2022.898819
work_keys_str_mv AT eichkornramonaa innateimmuneactivationascofactorinpemphigusdiseasemanifestation
AT schmidtmornaf innateimmuneactivationascofactorinpemphigusdiseasemanifestation
AT walterelias innateimmuneactivationascofactorinpemphigusdiseasemanifestation
AT hertlmichael innateimmuneactivationascofactorinpemphigusdiseasemanifestation
AT baronjensmalte innateimmuneactivationascofactorinpemphigusdiseasemanifestation
AT waschkejens innateimmuneactivationascofactorinpemphigusdiseasemanifestation
AT yazdiamirs innateimmuneactivationascofactorinpemphigusdiseasemanifestation